Abstract
A variety of mass spectrometric techniques have been employed in the study of a series of structurally similar compounds used in the treatment of hypertension. The compounds, known collectively as angiotensin-converting enzyme (ACE) inhibitors, all share the amino acid residue proline or some variant thereof, as a common structural element. The gas phase fragmentation behavior of these compounds has been explored systematically using various instruments and techniques. An interesting dissociation process (rearrangement) unique to one of the compounds, lisinopril, has been investigated using isotopic labeling experiments and exact mass measurements. The general nature of the process has been probed through both the positive and negative ion analyses of fourteen related compounds exhibiting structural homology.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Douglas, W. W. Polypeptides-Angiotensin, Plasma Kinins, and Others. In The Pharmacological Basis of Therapeutics, 7th ed.; Gilman, A.G.; Goodman, L.S.; Rall, T.W.; Murad, F., Eds.; Macmillan: New York, 1985; Chap XXVII, pp 639–659.
Natesh, R.; Schwager, S. L. U.; Sturrock, E. D.; Acharya, K. R. Crystal Structure of the Human Angiotensin-Converting Enzyme-Lisinopril Complex. Nature 2003, 421, 551–554.
Cushman, D. W.; Chenng, H. S.; Sabo, E. F.; Ondetti, M. A. Design of Potent Competitive Inhibitors of Angiotensin-Converting Enzyme. Carboxyalkanoyl and Mercaptoalkanoyl Amino Acids. Biochemistry 1977, 16, 5484–5491.
Ondetti, M. A.; Rubin, B.; Cushman, D. W. Design of Specific Inhibitors of a New Class of Orally Active Antihypertensive Agents. Science 1977, 196, 441–444.
Andrews, P. R.; Carson, J. M.; Casseli, A.; Spark, M. J.; Woods, R. Conformational Analysis and Active Site Modeling of Angiotensin-Converting Enzyme Inhibitors. J. Med. Chem. 1985, 28, 393–399.
Thorsett, E. D.; Harris, E.; Aster, S.; Peterson, E. R.; Snyder, J. P.; Hirshfield, J.; Tristram, E. W.; Patchett, A. A.; Ulm, E. H.; Vassil, T. C. Conformationally Restricted Inhibitors of Angiotensin Converting Enzyme: Synthesis and Computations. J. Med. Chem. 1986, 29, 251–260.
Laffan, R. J.; Goldberg, M. E.; High, J. P.; Schaeffer, R. R.; Waugh, M. H.; Rubin, B. Antihypertensive Activity in Rats of SQ 14225, an Orally Active Inhibitor of Angiotensin Converting Enzyme. J. Pharmocol. Exp. Ther. 1987, 204, 281–288.
Qin, X. Z.; Wang, Q.; Visentini, J.; Kwong, E. Detection and Identification of an Enalaprilat Isomer in Enalapril Formulations. J. Isol. Purif. 1997, 2, 275–288.
Sioufi, A.; Pommier, F.; Kaiser, G.; Dubois, J. P. Determination of Benazepril, a New Angiotensin-Converting Enzyme Inhibitor and Its Active Metabolite, Benazeprilat, in Plasma and Urine by Capillary Gas Chromatography Mass-Selective Detection. J. Chromatogr. 1988, 434, 239–246.
Tsaconas, C.; Devissaguet, M.; Padieu, P. Gas Chromatography Mass Spectrometry of Perindopril and Its Active Free Metabolite, an Angiotensin Convertase Inhibitor: Choice of Derivatives and Ionization Modes. J. Chromatogr. 1989, 488, 249–265.
Waldmeier, F.; Kaiser, G.; Ackermann, R.; Faigle, J. W.; Wagner, J.; Barner, A.; Lasseter, K. C. The Disposition of [14C]-Labeled Benazepril Hydrochloride in Normal Adult Volunteers After Single and Repeated Oral Dose. Xenobiotica 1991, 21, 251–261.
Goto, N.; Kamata, T.; Ikegami, K. Trace Analysis of Quinapril and Its Active Metabolite, Quinaprilat, in Human Plasma and Urine by Gas Chromatography Negative-Ion Chemical Ionization Mass Spectrometry. J. Chromatogr. 1992, 578, 195–201.
Lies, H. J.; Gleipach, H.; Windischhofer, W. Stable Isotope Labeling and Quantitative Determination of Enalaprilat in Human Plasma by GC-NICI-MS. J. Mass Spectrom. 1995, 30, 1447–1452.
Franklin, M. E.; Addison, R. S.; Baker, P. V.; Hooper, W. D. Improved Analytical Procedure for the Measurement of Captopril in Human Plasma by Gas Chromatography Mass Spectrometry and Its Application to Pharmacokinetic Studies. J. Chromatogr. B 1998, 705, 47–54.
Dal Bo, L.; Mazzucchelli, P.; Marzo, A. Assay of Zofenopril and Its Active Metabolite Zofenoprilat by Liquid Chromatography Coupled with Tandem Mass Spectrometry. J. Chromatogr. B 2000, 749, 287–294.
Zhu, Z.; Vachareau, A.; Neirinck, L. Liquid Chromatography Mass Spectrometry Method for Determination of Ramipril and Its Active Metabolite Ramiprilat in Human Plasma. J. Chromatogr. B 2002, 779, 297–306.
Fernandez, M. T.; Silva, M. M.; Mira, L.; Florêncio, M. H.; Gill, A.; Jennings, K. R. Iron and Copper Complexation by Angiotensin-Converting Enzyme Inhibitors. A Study by Ultraviolet Spectroscopy and Electrospray Mass Spectrometry. J. Inorg. Biochem. 1998, 71, 93–98.
Silva, C. M. L.; Duarte, M. F.; Mira, M. L.; Florêncio, M. H.; Versluis, K.; Heck, A. J. R. Copper and Iron Interactions with Angiotensin-Converting Enzyme Inhibitors. A Study by Fast-Atom Bombardment Tandem Mass Spectrometry. Rapid Commun. Mass Spectrom. 1999, 13, 1098–1103.
Florêncio, M. H.; Fernandez, M. T.; Mira, M. L.; Millar, A.; Jennings, K. R. Electrospray Mass Spectrometry of Angiotensin-Converting Enzyme Inhibitors. Rapid Commun. Mass Spectrom. 1998, 12, 1928–1932.
Cartoni, A.; Altamura, M.; Animati, F.; Balacco, G.; Cosi, R.; Ettorre, A.; Madami, A.; Triolo, A. An Unusual Rearrangement of Zofenopril, a New ACE Inhibitor Drug: Mass Spectrometric and Conformational Studies. J. Mass Spectrom. 2002, 37, 1258–1265.
Tyler, A.; Clayton, E.; Green, B. Exact Mass Measurement of Polar Organic Molecules at Low Resolution Using Electro spray Ionization and a Quadrupole Mass Spectrometer. Anal. Chem. 1996, 68, 3561–3569.
Olsen, M. A.; Cummings, P. G.; Kennedy-Gabb, S.; Wagner, B. M.; Nicol, G. R.; Munson, B. The Use of Deuterium Oxide as a Mobile Phase for Structural Elucidation by HPLC/UV/ESI/MS. Anal. Chem. 2000, 72, 5070–5078.
Wysocki, V. H.; Tsaprailis, G.; Smith, L. L.; Breci, L. A. Mobile and Localized Protons: A Framework for Understanding Peptide Dissociation. J. Mass Spectrom. 2000, 35, 1399–1406.
Roepstorff, P.; Fohlman, J. Proposal for a Common Nomenclature for Sequence Ions in Mass Spectra of Ppeptides. Biomed. Mass Spectrom. 1984, 11, 601.
Bowie, J. H.; Stringer, M. B.; Hayes, R. N.; Raftery, M. J.; Currie, G. J.; Eichinger, P. C. H. Collision Induced Dissociations of Enolate Negative Ions in the Gas Phase. Spectroscopy 1985, 4, 277–296.
Louris, J. N.; Cooks, R. G.; Syka, J. E. P.; Kelley, P. E.; Stafford, G. C.; Todd, J. F. J. Instrumentation, Applications, and Energy Deposition in Quadrupole Ion-Trap Mass Spectrometry. Anal. Chem. 1987, 59, 1677–1685.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online July 28, 2004
Rights and permissions
About this article
Cite this article
Burinsky, D.J., Sides, S.L. Mass spectral fragmentation reactions of angiotensin-converting enzyme (ACE) inhibitors. J Am Soc Mass Spectrom 15, 1300–1314 (2004). https://doi.org/10.1016/j.jasms.2004.05.010
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/j.jasms.2004.05.010